Abstract
Doxorubicin treatment outcomes for non-Hodgkin’s lymphomas (NHL) are mathematically modelled and computationally analyzed. The NHL model includes a tumor structure incorporating mature and immature vessels, vascular structural adaptation and NHL cell-cycle kinetics in addition to Doxorubicin pharmacokinetics (PK) and pharmacodynamics (PD). Simulations provide qualitative estimations of the effect of Doxorubicin on high-grade (HG), intermediate-grade (IG) and low-grade (LG) NHL. Simulation results imply that if the interval between successive drug applications is prolonged beyond a certain point, treatment will be inefficient due to effects caused by heterogeneous blood flow in the system.
Similar content being viewed by others
References
Agur, Z., 1985. Randomness, synchrony and population persistence. J. Theor. Biol. 112, 677–693.
Agur, Z., Arnon, R., Schechter, B., 1988. Reduction of cytotoxicity to normal tissues by new regimens of phasespecific drugs. Math. Biosci. 92, 1–15.
Alarcón, T., Byrne, H.M., Maini, P.K., 2003. A cellular automaton model for tumor growth in inhomogeneous environment. J. Theor. Biol. 225, 257–274.
Alarcń, T., Byrne, H.M., Maini, P.K., Design principle of vascular beds: effects of blood rheology (in preparation).
Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., Watson, J.D., 1994. Molecular Biology of the Cell. Garland Publishing, New York and London.
Al-Ismail, S.A., Whittaker, J.A., Gough, J., 1987. Combination chemotherapy including Epirubicin for the management of non-Hodgkin’s lymphoma. Eur. J. Cancer Clin. Oncol. 23, 1379–1384.
Anderson, A.R.A., Chaplain, M.A.J., 1998. Continuous and discrete mathematical models of tumour-induced angiogenesis. Bull. Math. Biol. 60, 857–899.
Anderson, A.R.A., Chaplain, M.A.J., Newman, E.L., Steele, R.J.C., Thompson, A.M., 2000. Mathematical modelling of tumor invasion and metastasis. J. Theor. Med. 2, 129–154.
Arakelyan, L., Vainstein, V., Agur, Z., 2002. A computer algorithm describing the process of vessel formation and maturation and its use for predicting the effects of anti-angiogenic and multi-maturation therapy on vascular tumor growth. Angiogenesis 5, 203–214.
Barranco, S.C., 1984. Cellular and molecular effects of Adriamycin on dividing and nondividing cells. Pharmacol. Ther. 24, 303–319.
Bast, R.C., Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Holland, J.F., 2000. Cancer Medicine. BC Decker Inc, Canada.
Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., Keshet, E., 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 157–158.
Blagosklonny, M.V., Pardee, A.B., 2002. The restriction point of the cell cycle. Cell Cycle 1, 103–110.
Boring, C.C., Squires, T.S., Tong, T., Montgomery, S., 1994. Cancer statistics, 1994. C.A. Cancer J. Clin. 44, 7–26.
Brons, P.P., Raemaekers, J.M., Bogman, M.J., van Erp, P.E., Boezeman, J.B., Pennings, A.H., Wessels, H.M, Haanen, C., 1992. Cell cycle kinetics in malignant lymphoma studied with in vivo Iodeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood 1 80, 2336–2343.
Casciari, J.J., Sotirchos, S.V., Sutherland, R.M., 1998. Glucose diffusivity in multicellular tumor spheroids. Cancer Res. 48, 3905–3909.
Cojocaru, L., Agur, Z., 1992. A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs. Math. Biosci. 109, 85–97.
Couderc, B., Dujols, J.P., Mokhtari, F., Norkowski, J.L., Slawinski, J.C., Schlaifer, D., 2000. The management of adult aggressive non-Hodgkin’s lymphomas. Crit. Rev. Oncol. Hematol. 35, 33–48.
Crone, C., Levitt, D.G., 1984. Handbook of Physiology: A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts. American Physiological Society, Bethesda, ML.
Deutsch, A., Dormann, S., 2002. Modeling of avascular tumor growth with a hybrid cellular automaton. In Silico Biol. 2, 1–14.
Enden, G, Popel, A.S., 1994. A numerical study of plasma skimming in small vascular bifurcations. J. Biomech. Eng. 116, 79–88.
Erlanson, M., Lindth, J., Zackrisson, B., Landberg, G., Roos, G., 1995. Cell kinetic analysis of non-Hodgkin’s lymphomas using in vivo Iodeoxyuridine incorporation and flow cytometry. Hematol. Oncol. 13, 207–217.
Hackbusch, W., 1985. Multigrid Methods and Applications. Springer, Berlin.
Hardman, J.G., Limbird, L.E., Gilman, A.G., 2001. The Pharmacological Basis of Therapeutics. McGraw-Hill Companies.
Honda, H., Yoshizato, K., 1997. Formation of branching pattern of blood vessels in the wall of the avian yolk sac studied by computer simulation. Dev. Growth Differ. 39, 581–589.
Jain, R.K., 2001. Delivery of molecular and cellular medicine to solid tumours. Adv. Drug. Deliv. Rev. 46, 146–168.
Konerding, M.A., Fait, E., Gaumann, A., 2001. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br. J. Cancer. 84, 1354–1362.
Kwok, T.T., Twentyman, P.R., 1985. The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroid. Br. J. Cancer. 51, 211–218.
Lankelma, J., Luque, R.F., Dekker, H., Schinkel, W., Pinedo, H., 2000. A mathematical model of drug transport in human breast cancer. Microvasc. Res. 59, 149–161.
Lapela, M., Leskinen, S., Minn, H.R., Lindholm, P., Klemi, P.J., Soderstrom, K.O., Bergman, J., Haaparanta, M., Ruotsalainen, U., Solin, O., 1995. Increased glucose metabolism in untreated non-Hodgkin’s lymphoma: a study with positron emission tomography and fluorine-19-fluorodeoxyglucose. Blood 1 86, 3522–3527.
Lepage, E., Gisselbrecht, C., Haioun, C., Sebban, C., Tilly, H., Bosly, A., Morel, P., Herbrecht, R., Reyes, F., Coiffier, B., 1993. Prognostic significance of received relative dose intensity in non-Hodgkin’s lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d’Etude des Lymphomes de l’Adulte). Ann. Oncol. 4, 651–656.
Liotta, L.A., Saidel, G.M., Kleinerman, J., 1977. Diffusion model of tumor vascularization and growth. Bull. Math. Biol. 39, 117–128.
McCormick, S.F., 1987. Multigrid Methods. SIAM, Philadelphia.
McDougall, S.R., Anderson, A.R.A., Chaplain, M.A.J., Sherratt, J.A., 2002. Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies. Bull. Math. Biol. 64, 673–702.
Nagai, K., Nagasawa, K., Sadzuka, Y., Tsujimoto, M., Takara, K., Ohnishi, N., Yokoyama, T., Fujimoto, S., 2002. Relationships between the in vitro cytotoxicity and transport characteristics of Pirarubicin and Doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells. Cancer Chemother. Pharmacol. 49, 244–250.
Orme, M.E., Chaplain, M.A.J., 1996. A mathematical model of vascular tumour growth and invasion. Math. Comput. Modelling 23, 43–60.
Patel, A.A., Gawlinski, E.T., Lemieux, S.K., Gatenby, R.A., 2001. A cellular automaton model of early tumor growth and invasion. J. Theor. Biol. 7 213, 315–331.
Pries, A.R., Secomb, T.W., Gaehtgens, P., 1998. Structural adaptation and stability of microvascular networks: theory and simulations. Am. J. Physiol. 275, H349–H360.
Pries, A.R., Secomb, T.W., Gessner, T., Sperandio, M.B., Gross, J.F., Gaehtgens, P., 1994. Resistance to blood flow in microvessels in vivo. Circ. Res. 75, 904–915.
Stokke, T., Holte, H., Smedshammer, L., Smeland, E.B., Kaalhus, O., Steen, H.B., 1998. Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin’s lymphomas. Br. J. Cancer 77, 1832–1838.
Willemse, F., Nap, M., de Bruijn H.W.A., Hollema, H., Morphological parameters of vasculature in tumor marker biodynamics. Anal. Quant. Histol. (in press).
Wilson, J.D, Foster, D.W., 1992. Williams Textbook of Endocrinology. W.B. Saunders Company.
Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., Holash, J., 2000. Vascular specific growth factors and blood vessel formation. Nature 407, 242–248.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ribba, B., Marron, K., Agur, Z. et al. A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin’s lymphoma: Investigation of the current protocol through theoretical modelling results. Bull. Math. Biol. 67, 79–99 (2005). https://doi.org/10.1016/j.bulm.2004.06.007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/j.bulm.2004.06.007